| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | Puma Biotechnology Inc | May 15, 2019 | |
| Buy | Puma Biotechnology Inc | Jan 23, 2019 | |
| Buy | PUMA BIOTECHNOLOGY INC. CMN | Aug 29, 2017 | |
| Sell | Puma Biotechnology Inc | Sep 26, 2014 | |
| Buy | Puma Biotechnology Inc | Sep 10, 2014 | |
| Buy | Puma Biotechnology Inc | Jul 30, 2014 | |
| Buy | Puma Biotechnology Inc | Jul 24, 2014 | |
| Sell | Puma Biotechnology Inc | Jul 23, 2014 |
This page tracks congressional stock trading activity in Puma Biotechnology, Inc. (PBYI) in the Healthcare sector. Disclosed Capitol has indexed 8 disclosed congressional trades involving PBYI. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of May 2019 — Disclosed Capitol has tracked 8 disclosed congressional trades in Puma Biotechnology, Inc. (PBYI) — 3:1 sell-heavy ratio — led by Nick J. Rahall (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| May 15, 2019 | Donna Shalala | D | Sale | $1,001 - $15,000 |
| Jan 23, 2019 | Donna Shalala | D | Buy | $1,001 - $15,000 |
| Aug 29, 2017 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Sep 26, 2014 | Nick J. Rahall | D | Sale | $1,001 - $15,000 |
| Sep 10, 2014 | Nick J. Rahall | D | Buy | $1,001 - $15,000 |
| Jul 30, 2014 | Nick J. Rahall | D | Buy | $1,001 - $15,000 |
| Jul 24, 2014 | Nick J. Rahall | D | Buy | $15,001 - $50,000 |
| Jul 23, 2014 | Nick J. Rahall | D | Sale | $15,001 - $50,000 |
Across the 8 disclosed congressional trades in Puma Biotechnology, Inc. (PBYI), members of Congress have reported 1 buy and 3 sells. The average 30-day alpha vs. the S&P 500 is 14.04%.
As of July 2026, corporate insiders at Puma Biotechnology, Inc. have filed 3 SEC Form 4 transactions in PBYI over the past 12 months — including 3 sells worth $512K.
| Date | Insider | Action | Value |
|---|---|---|---|
| 2026-07-06 | AUERBACH ALAN H — President and CEO | Sale | $364K |
| 2026-07-06 | HUNT DOUGLAS M — See Remarks | Sale | $70K |
| 2026-07-06 | NOUGUES MAXIMO F — Chief Financial Officer | Sale | $78K |
Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.
As of June 2020, Puma Biotechnology, Inc. has 2 federal contract award records on file from USAspending.gov — most recently -$79K from the Department of Veterans Affairs on 2020-06-10.
| Award date | Agency | Amount |
|---|---|---|
| 2020-06-10 | Department of Veterans Affairs | -$79K |
| 2018-06-25 | Department of Veterans Affairs | $95K |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, Puma Biotechnology, Inc. reported revenue of $235.6M and net income of $21.6M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $56.5M, net income $8.2M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.